Director Biostatistics

Director of Biostatistics – Oncology / Immuno-Oncology Location: UK (remote flexibility offered) We are seeking an accomplished Director of Biostatistics to join our client's Global Biostatistics & Programming team. This strategic, individual contributor role will focus on Oncology and Immuno-Oncology programs across all clinical phases (with an emphasis on Phases I–III), providing expert statistical leadership to advance their cutting-edge pipeline. This is a high-impact role with broad visibility across Clinical Development, offering the opportunity to shape development strategy and influence key decisions at a global level. Key Responsibilities: Provide strategic statistical leadership for Clinical Development Plans in Oncology / Immuno-Oncology programs. Collaborate closely with Clinical Development, Regulatory Affairs, Biomarkers, Medical Affairs, and other key stakeholders to drive data-driven decisions. Oversee all statistical activities for assigned programs, including study design, analysis planning, and regulatory submission support . Partner with Study Statisticians to ensure statistical rigor across study-level deliverables. Support regulatory interactions and global submission packages, providing expert input on statistical methodology and documentation. Apply advanced statistical methods including Bayesian frameworks and survival analysis to guide innovative trial design and interpretation. Lead cross-functional teams and influence development strategies without formal line management responsibilities. Ideal Candidate Profile: PhD or MSc in Biostatistics, Statistics, or a related field. Extensive experience (10 years) in clinical biostatistics, with a focus on oncology or immuno-oncology drug development. Proven track record of statistical leadership in Phase I–III clinical trials . Demonstrated ability to provide strategic input to early and late-stage development programs. Expertise in statistical methodologies relevant to oncology, including Bayesian approaches and survival models . Strong experience with regulatory submissions , including responding to Health Authority queries. Skilled in leading cross-functional teams , influencing without authority, and coordinating statistical input across diverse functions (e.g., Biomarkers, Medical Affairs). Ability to work independently as a high-level individual contributor in a global matrix environment. What your can expect: Opportunity to shape the development of innovative oncology therapies with global impact. A collaborative, forward-thinking environment that values scientific excellence and innovation. Competitive compensation package, including bonus and long-term incentives. Flexible work arrangements and a commitment to work-life balance. Confidential inquiries are welcome at czaharia@planet-pharma.co.uk About Planet Pharma: Planet Pharma is an American parented Employment Business/Agency that provides global staffing services with its head-quarters in Chicago and our EMEA regional office located in Central London. We have invested significantly in creating a robust international platform that enables us to work compliantly in 30 countries with a current network of 2500 active contractors globally as well as a very strong permanent / direct hire recruitment offering. Our specialist knowledge and close relationships with our clients and the wider industry really makes us unique in our field. Just recently we were recognised by FORBES as the 17th best professional staffing firm, and have won multiple awards from industry accredited bodies for our commitment to excellence and service delivery. We have extensive functional expertise including: Regulatory Affairs, Pharmacovigilance, QA, QC, Submissions experts, Clinical development, Quality, Biostatistics, and Medical Affairs / Writing. We are an equal opportunities Recruitment Business and Agency. We welcome applications from all suitably qualified candidates regardless of their race, sex, disability, religion/belief, sexual orientation or age. www.planet-pharma.com

Location: UK, GB

Posted Date: 8/2/2025